<DOC>
	<DOCNO>NCT00215813</DOCNO>
	<brief_summary>This open label study Ampligen patient chronic fatigue syndrome .</brief_summary>
	<brief_title>Ampligen Chronic Fatigue Syndrome</brief_title>
	<detailed_description>An Open-Label Study Poly I : Poly C12U ( AmpligenÂ® ) Patients Severely Debilitating Chronic Fatigue Syndrome ( CFS ) /Myalgic Encephalomyelitis ( ME ) . The FDA approve study cost recovery . Patients enrol study responsible cost related therapy , e.g. , drug cost , infusion cost , cost supply , diagnostic laboratory testing .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>poly ( I ) .poly ( c12 , U )</mesh_term>
	<mesh_term>Poly I-C</mesh_term>
	<criteria>1 . Diagnosis Chronic Fatigue Syndrome ( &gt; = 12 month ) define 1988 Centers Disease Control Prevention CDC case definition CFS define 1994 CDC case definition CFS ( Fukuda et al. , Ann Intern Med . 1994 ; 121:953959 ) ( clinical condition could present similar symptom must excluded. ) . 2 . Age Range : &gt; = 18 year old , &lt; = 70 year old . 3 . Males nonpregnant , nonlactating female : Females must nonchild bear potential ( either postmenopausal two year surgically sterile include tubal ligation ) use effective mean contraception ( birth control pill , intrauterine device , diaphragm ) . Alternatively , female patient male partner successful vasectomy ( consider successful volunteer report male partner either documentation azoospermia microscopy vasectomy 2 year ago resultant pregnancy despite sexual activity postvasectomy ) .Females less two ( 2 ) year postmenopausal , tubal ligation use contraception must negative serum pregnancy test baseline within four ( 4 ) week prior first study medication infusion . Every four week , study termination pregnancy test perform , either serum urine stick test . However , urine result positive , serum pregnancy test perform . Females child bear potential agree use effective mean contraception four ( 4 ) week prior baseline pregnancy test four ( 4 ) week last study medication infusion . All male patient agree sperm donor use effective mean contraception study medication 90 day last study medication infusion . 4 . A reduced quality life determine Karnofsky performance score ( KPS ) &gt; = 20 &lt; = 60 . The KPS must round increment ten ( 10 ) . 5 . Ability provide write informed consent indicate awareness investigational nature study . 6 . Documentation ( baseline historically follow onset CFS ) negative ANA negative antids ( doublestranded ) DNA , negative Rheumatoid Factor , erythrocyte sedimentation rate ( ESR ) . Documentation baseline normal T4 ( laboratory evidence subject euthyroid ) also require . 1 . Inability return schedule treatment assessment . 2 . Chronic intercurrent acute medical disorder disease make implementation interpretation protocol result difficult unsafe . 3 . Pregnant lactating female . 4 . Therapy interferon , interleukin , cytokine investigational drug within 6 week begin study medication . Subjects must give write informed consent prior discontinuation investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Chronic Fatigue Syndrome</keyword>
	<keyword>CFS</keyword>
	<keyword>ME</keyword>
	<keyword>Ampligen</keyword>
	<keyword>poly I : poly C12U</keyword>
	<keyword>Rintatolimod</keyword>
</DOC>